ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVTA Invitae Corporation

0.0891
0.00 (0.00%)
Apr 29 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Invitae Corporation NVTA NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0891 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.0891 0.0891
more quote information »

Recent News

Date Time Source Heading
3/06/202407:31EDGAR2Form 8-K - Current report
2/06/202416:07EDGAR2Form 8-K - Current report
1/30/202406:00PRNUSInvitae Partners with BridgeBio Pharma to Harness Genetic..
1/29/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202415:34EDGAR2Form 8-K/A - Current report: [Amend]
1/22/202406:05EDGAR2Form 8-K - Current report
1/22/202406:00PRNUSInvitae Completes Sale of Reproductive Health Assets to..
1/18/202415:10EDGAR2Form 8-K - Current report
12/21/202320:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202315:29EDGAR2Form 8-K - Current report
12/13/202315:07PRNUSInvitae Divests Ciitizen Health Data Platform and Implements..
12/11/202315:41EDGAR2Form 8-K - Current report
11/17/202315:48EDGAR2Form 8-K - Current report
11/15/202315:22EDGAR2Form 8-K - Current report
11/14/202318:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/08/202315:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:05EDGAR2Form 8-K - Current report
11/08/202315:01PRNUSInvitae Reports Third Quarter 2023 Financial Results
11/06/202315:00PRNUSInvitae Launches Enhanced Chemistry of MRD Test to Better..
11/01/202305:59PRNUSInvitae to Announce Third Quarter 2023 Financial Results on..
10/25/202310:00PRNUSLandmark Study Reveals Magnitude of Uncertain Results in..
10/20/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202315:38EDGAR2Form 8-K - Current report
10/19/202315:30PRNUSInvitae Appoints Dr. David Sholehvar as Chief Operating..
10/12/202315:15PRNUSRural Hospital System Demonstrates the Clinical Benefits of..
10/10/202315:30PRNUSInvitae to Present Data at the National Society of Genetic..
10/03/202311:07PRNUSInvitae's Common Hereditary Cancers Panel Receives FDA..
10/02/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202319:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/29/202319:00DJNFDA Gives Marketing Authorization to Invitae Test for Cancer..
9/27/202315:29EDGAR2Form 8-K - Current report
9/25/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202315:30PRNUSInvitae Announces Appointment of Finance Veteran Ana Schrank..
9/22/202316:02EDGAR2Form 8-K - Current report
9/22/202315:30PRNUSInvitae Receives Notice of Non-Compliance with NYSE Minimum..
9/14/202316:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/28/202315:02PRNUSInvitae Hires Industry Veteran Robert Guigley as Chief..
8/23/202307:12EDGAR2Form 8-K - Current report
8/15/202306:30PRNUSClinical Trial Results Support Genetic Testing of All..
8/14/202315:02PRNUSInvitae Announces Selection of Finance Executive Robert..
8/10/202315:03EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/10/202315:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/09/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/09/202308:22EDGAR2Form POS AM - Post-Effective amendments for registration..
8/09/202308:20EDGAR2Form POS AM - Post-Effective amendments for registration..
8/08/202315:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:09EDGAR2Form 8-K - Current report
8/08/202315:01PRNUSInvitae Reports Second Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock